The intermediates formed during the activation of prothrombin in 25% sodium citrate solutions have been isolated and partially characterized. Their properties are in agreement with those predicted by a previously proposed model for prothrombin activation in 25% sodium citrate: prothrombin (72,000 daltons) → intermediate 1 (65,000 daltons) → Intermediate 2 (39,000 daltons) and Intermediate 3 (25,000 daltons); Intermediate 2 (39,000 daltons) → thrombin (α-thrombin, 39,000 daltons) (Mann, K. G., Heldebrant, C. M., and Fass, D. N. (1971) J. Biol Chem. 246, 6106–6114). Intermediates 1 and 2, as predicted, can be activated to thrombin, while Intermediate 3 cannot. The chromatographic behavior of Intermediate 2 is nearly identical with that of thrombin. Molecular weight and amino acid composition data strongly suggest that α-thrombin is formed from Intermediate 2 by the loss of little, if any, of the Intermediate 2 sequence. Intermediates 2 and 3 are shown to be substantially independent portions of the prothrombin sequence. The tryptic peptides derived from Intermediates 2 and 3, while very dissimilar account for greater than 85% of the tryptic peptides derived from prothrombin. Furthermore, Intermediate 3 contains nearly twice as much half-cystine and more than twice as much neutral sugar as Intermediate 2. A product of prothrombin activation, apparently derived from Intermediate 3, has been shown to alter the activity of thrombin toward N-α-tosyl-l-arginine methyl ester and fibrinogen. The possibility that a thrombin of altered specificity may participate in the control and regulation of coagulation is discussed.
No takes yet. Share an insight, caveat, or question.
Heldebrant et al. (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: